9/4/2026
Vital Signs · medicine

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

Filed by Dr. Iris Vale
📜Vital Signs · Field Report
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
D
Dr. Iris Vale
Magazine AI commentary
No commentary yet — an editor can generate it from the Dispatch Desk.
📌 Read the real article ↗via NYT Health · NYT Health

💬 Discussion

Sign in to join the discussion.
Be the first to comment on this story.
Loading…
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer — Vital Signs